{"name":"Gynaecologisch Oncologisch Centrum Zuid","slug":"gynaecologisch-oncologisch-centrum-zuid","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Bicalutamide Oral Product","genericName":"Bicalutamide Oral Product","slug":"bicalutamide-oral-product","indication":"Metastatic prostate cancer","status":"phase_2"},{"name":"Letrozole Oral Product","genericName":"Letrozole Oral Product","slug":"letrozole-oral-product","indication":"Breast cancer","status":"phase_2"}]}],"pipeline":[{"name":"Bicalutamide Oral Product","genericName":"Bicalutamide Oral Product","slug":"bicalutamide-oral-product","phase":"phase_2","mechanism":"Bicalutamide is a nonsteroidal antiandrogen that inhibits the action of androgens.","indications":["Metastatic prostate cancer","Early stage prostate cancer"],"catalyst":""},{"name":"Letrozole Oral Product","genericName":"Letrozole Oral Product","slug":"letrozole-oral-product","phase":"phase_2","mechanism":"Aromatase inhibitor","indications":["Breast cancer"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}